These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27779786)

  • 1. Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure.
    Yen DC; Watson MH; Burgess LD; Kuchibhatla M; Patel CB; Campbell KB; Vora AK
    Pharmacotherapy; 2016 Dec; 36(12):1210-1216. PubMed ID: 27779786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in glycemic control after left ventricular assist device implantation in advanced heart failure patients with diabetes mellitus.
    Choudhary N; Chen L; Kotyra L; Wittlin SD; Alexis JD
    ASAIO J; 2014; 60(6):675-80. PubMed ID: 25232763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience.
    Asleh R; Briasoulis A; Schettle SD; Tchantchaleishvili V; Pereira NL; Edwards BS; Clavell AL; Maltais S; Joyce DL; Joyce LD; Daly RC; Kushwaha SS; Stulak JM
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device.
    Koerner MM; El-Banayosy A; Eleuteri K; Kline C; Stephenson E; Pae W; Ghodsizad A
    Heart Surg Forum; 2014 Apr; 17(2):E98-102. PubMed ID: 24808450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of left ventricular assist device on diabetes management: an evaluation through case analysis and clinical impact.
    Subauste AR; Esfandiari NH; Qu Y; Oral EA; Aaronson KD; Pagani FD; Gianchandani RG
    Hosp Pract (1995); 2014 Aug; 42(3):116-22. PubMed ID: 25255413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis.
    Ruiz-Negrón N; Wander C; McAdam-Marx C; Pesa J; Bailey RA; Bellows BK
    J Manag Care Spec Pharm; 2019 Mar; 25(3):304-313. PubMed ID: 30816810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Diabetes Mellitus a Risk Factor for Poor Outcomes after Left Ventricular Assist Device Placement?
    Mohamedali B; Yost G; Bhat G
    Tex Heart Inst J; 2017 Apr; 44(2):115-119. PubMed ID: 28461796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices.
    Uriel N; Naka Y; Colombo PC; Farr M; Pak SW; Cotarlan V; Albu JB; Gallagher D; Mancini D; Ginsberg HN; Jorde UP
    Eur J Heart Fail; 2011 Feb; 13(2):195-9. PubMed ID: 21098576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation of Left Ventricular Assist Device Results in Immediate Improvement of Glucose Metabolism in Patients With and Without Diabetes Mellitus.
    Goetz ME; Charnigo R; Guglin M
    Heart Lung Circ; 2020 Jun; 29(6):931-935. PubMed ID: 31235366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical circulatory support improves diabetic control in patients with advanced heart failure.
    Mohamedali B; Yost G; Bhat G
    Eur J Heart Fail; 2014 Oct; 16(10):1120-4. PubMed ID: 25298334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes.
    Nguyen AB; Imamura T; Besser S; Rodgers D; Chung B; Raikhelkar J; Kalantari S; Smith B; Sarswat N; LaBuhn C; Jeevanandam V; Kim G; Sayer G; Uriel N
    J Am Heart Assoc; 2019 Nov; 8(22):e013278. PubMed ID: 31718441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal Muscle Mass Recovery Early After Left Ventricular Assist Device Implantation in Patients With Advanced Systolic Heart Failure.
    Vest AR; Wong WW; Chery J; Coston A; Telfer L; Lawrence M; Celkupa D; Kiernan MS; Couper G; Kawabori M; Saltzman E
    Circ Heart Fail; 2022 May; 15(5):e009012. PubMed ID: 35378982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Diabetes Mellitus on Outcomes in Patients After Left Ventricular Assist Device Implantation.
    Usoh CO; Sherazi S; Szepietowska B; Kutyifa V; McNitt S; Papernov A; Wang M; Alexis JD
    Ann Thorac Surg; 2018 Aug; 106(2):555-560. PubMed ID: 29577927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular assist device implantation improves glycaemic control: a systematic review and meta-analysis.
    Patel N; Gluck JA; Radojevic J; Coleman CI; Baker WL
    ESC Heart Fail; 2018 Dec; 5(6):1141-1149. PubMed ID: 30052326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an Electronic Medical Record (EMR) to Identify Glycemic Intensification Strategies in Type 2 Diabetes.
    Korytkowski MT; Brooks M; Lombardero M; DeAlmeida D; Kanter J; Magaji V; Orchard T; Siminerio L
    J Diabetes Sci Technol; 2015 May; 9(3):593-601. PubMed ID: 25526759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in blood glucose control in patients with diabetes after implantation of left ventricular assist devices.
    Guglin M; Maguire K; Missimer T; Faber C; Caldeira C
    ASAIO J; 2014; 60(3):290-3. PubMed ID: 24614357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can a Left Ventricular Assist Device in Individuals with Advanced Systolic Heart Failure Improve or Reverse Frailty?
    Maurer MS; Horn E; Reyentovich A; Dickson VV; Pinney S; Goldwater D; Goldstein NE; Jimenez O; Teruya S; Goldsmith J; Helmke S; Yuzefpolskaya M; Reeves GR
    J Am Geriatr Soc; 2017 Nov; 65(11):2383-2390. PubMed ID: 28940248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Impact of Diabetes Mellitus on Short-Term Outcomes andIn-Hospital Mortality of Cardiac Mechanical Support with Left Ventricular Assist Device (LVAD): A Retrospective Study from a National Database.
    Yassin AS; Subahi A; Adegbala O; Abubakar H; Akintoye E; Ahmed A; Ismail A; Elhag A; Kambal A; Alade A; Shokr M; Weinberger J; Levine D; Afonso L
    Cardiovasc Revasc Med; 2019 Oct; 20(10):883-886. PubMed ID: 30578171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes.
    Lin SD; Tsai ST; Tu ST; Su CC; Chen JF; Lu CH; Wang CH; Yu NC; Hsu SR; Hsieh MC
    Prim Care Diabetes; 2015 Apr; 9(2):135-41. PubMed ID: 25266893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.